Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Dis ; 216(11): 1415-1424, 2017 12 12.
Article in English | MEDLINE | ID: mdl-28968792

ABSTRACT

HLA-B*52:01-C*12:02, which is found in approximately 20% of all Japanese persons, is well known to be associated with ulcerative colitis and Takayasu arteritis. This haplotype is also known to be protective in individuals infected with human immunodeficiency virus (HIV) type 1. Recent studies showed that HLA-B*52:01-restricted HIV-1-specific T cells suppress HIV-1 and that HLA-C*12:02 together with KIR2DL2 play an important role in natural killer cell-mediated control of HIV-1. However, the role of HLA-C*12:02-restricted cytotoxic T lymphocytes (CTLs) in suppressing HIV-1 replication remains unknown. In the present study, we demonstrated that HLA-C*12:02-restricted CTLs specific for 2 immunodominant epitopes, Pol IY11 and Nef MY9, contributed to the suppression of HIV-1 replication in HIV-1-infected individuals. Further analysis demonstrated that these 2 HLA-C*12:02-restricted CTLs together with 4 HLA-B*52:01-restricted ones effectively suppressed HIV-1 in individuals with the HLA-B*52:01-C*12:02 haplotype. Thus, both HLA-C*12:02 and HLA-B*52:01 alleles contribute to HIV-1 suppression via both HIV-1-specific CTLs and natural killer cells in individuals with this haplotype.


Subject(s)
HIV-1/drug effects , HLA-B Antigens/pharmacology , HLA-B52 Antigen/pharmacology , HLA-C Antigens/pharmacology , Haplotypes/immunology , Alleles , Cell Line , Chromium/analysis , Cytokines/analysis , Epitopes, T-Lymphocyte , HIV Infections/diet therapy , HIV Infections/immunology , HIV Infections/virology , HLA-B Antigens/immunology , HLA-B52 Antigen/immunology , HLA-C Antigens/immunology , HLA-C Antigens/isolation & purification , Host-Pathogen Interactions , Humans , Immunodominant Epitopes/pharmacology , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Receptors, KIR2DL2/physiology , T-Lymphocytes, Cytotoxic/drug effects , T-Lymphocytes, Cytotoxic/immunology , Virus Replication/drug effects , nef Gene Products, Human Immunodeficiency Virus/immunology , nef Gene Products, Human Immunodeficiency Virus/pharmacology , pol Gene Products, Human Immunodeficiency Virus/immunology , pol Gene Products, Human Immunodeficiency Virus/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...